Around 7,000 people in the UK develop primary brain cancer each year but only ten per cent of patients are still alive five years after diagnosis. A new research project has been awarded a grant of over £200,000 to look at a pathway in brain tumours called peroxisome proliferator-activated receptor (PPAR) and identify any possible new drug targets to treat the disease.
A new book by a University of Bristol academic explores the history of healthcare in the days before the NHS.
At-Bristol Science Centre, in collaboration with the University of Bristol, has been awarded a grant from the Wellcome Trust, in a UK first to lead an innovative and immersive series of workshops, using real human brain tissue to stimulate discussion about the social, ethical and legal issues around neuroscience and neuroscience research.
Children of the 90s, a health study based at the University of Bristol, has today published results from a study testing almost 5,000 participants for COVID-19 antibodies. 4.3% reported a positive result, of which a quarter were asymptomatic and did not report any symptoms in previous questionnaires.
Over 1,600 visitors are booked to attend the University of Bristol’s first institution-wide postgraduate open day on Wednesday [23 November].
Electric scooter schemes appear to reduce the risk of bicycle collisions by around 20%, according to a University of Bristol-led study. The research, funded by the National Institute for Health and Care Research (NIHR), is published in Injury Prevention today [21 March].
A new research project is asking for people with diabetes and their carers to take part in a UK-wide online survey that aims to identify how to best support people with the condition during the pandemic.
COVID-19 has had an enormous impact on nearly every aspect of our everyday lives. In response, researchers from the University of Bristol are working together and with partners around the world to understand the virus, develop a vaccine and help bring an end to the pandemic.
New posters, a booklet and an animation, co-designed by service users from Bristol Drugs Project, are being launched later this month to promote the benefits of low dead space injecting equipment for people who inject drugs, alongside broader harm reduction messages.
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the PoliValve could last for up to 25 years.
